Crossmark

Remimazolam should be antagonized by an adequate flumazenil

Crossref DOI link: https://doi.org/10.1007/s00540-022-03117-9

Published Online: 2022-10-05

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sato, Takehito https://orcid.org/0000-0001-5025-4250
Nishiwaki, Kimitoshi
License Information

Text and Data Mining valid from 2022-10-05

Version of Record valid from 2022-10-05
More Information

Article History

Received: 26 September 2022

Accepted: 29 September 2022

First Online: 5 October 2022

Declarations

:

: None.